Previous Article | Next Article 
Journal of Clinical Microbiology, July 2000, p. 2788-2790, Vol. 38, No. 7
0095-1137/00/$04.00+0
Copyright © 2000, American Society for Microbiology. All rights reserved.
Bacteriological and Serological Findings in a
Further Case of Transfusion-Mediated Yersinia
enterocolitica Sepsis
E.
Strobel,1,*
J.
Heesemann,2
G.
Mayer,3
J.
Peters,4
S.
Müller-Weihrich,4 and
P.
Emmerling1
Institut für Medizinische
Mikrobiologie, Immunologie und Krankenhaushygiene, Städtisches
Krankenhaus München-Schwabing,1
Max von Pettenkofer-Institut, Ludwig
Maximilians-Universität München,2
Amtlicher Blutspendedienst der Landeshauptstadt
München,3 and Kinderklinik,
Städtisches Krankenhaus München-Schwabing, and Technische
Universität München,4 Munich,
Germany
Received 4 February 2000/Returned for modification 18 March
2000/Accepted 29 April 2000
 |
ABSTRACT |
A 13-year-old patient developed severe shock due to administration
of a Yersinia enterocolitica-contaminated red blood cell concentrate. Y. enterocolitica (serotype O:9, biotype II)
was cultivated from the residual blood in the blood bag and from a stool sample of the blood donor. In the donor's plasma immunoglobulin M (IgM), IgA, and IgG antibodies against Yersinia outer
proteins (YopM, -H, -D, and -E) were found. Since the donor remembered a short-lasting, mild diarrhea 14 days prior to blood donation, a
transient attack of Yersinia enteritis may be associated
with a longer than expected period of asymptomatic bacteremia that causes contamination of donor blood. Serological screening for IgM
antibodies against Yersinia outer proteins might offer a
way to reduce the risk of transfusion-associated Y. enterocolitica sepsis.
 |
CASE REPORT |
We report the case of a 13-year-old girl suffering from lung
metastases of an osteoblastic sarcoma.
She required chemotherapy and consecutive
substitution of blood products. About 30 min after the beginning of the
transfusion of a red blood cell concentrate (RBCC) she developed
chills, abdominal pain, nausea, vomiting, pallor, tachypnea, dyspnea,
and cough. The transfusion was stopped immediately, and the patient was
admitted to the intensive care unit. Blood pressure was 95/60 torr, and
heart rate was 170 beats/min. Arterial blood gas analysis showed
hypoxemia (partial pressure of O2, 53 torr). Chest X-ray
revealed pulmonary edema. Echocardiographically, the function of both
ventricles was markedly impaired (acute deterioration of a preexisting
adriamycin-induced cardiomyopathy). There was no evidence of acute
intravascular hemolysis (normal haptoglobin and total bilirubin
values). Red blood cell compatibility was reexamined immediately after
the event and found to be inconspicuous. Half a day after the
transfusion, a Gram-stained blood smear was prepared directly from the
residual blood in the blood bag. It showed numerous gram-negative rods.
Intravenous antibiotics (ceftazidime, gentamicin, and ampicillin) were
started, and preexisting oral therapy with cotrimoxazole, polymyxin,
and nystatin was continued. The patient's condition improved slowly,
and she was discharged from the intensive care unit after 8 days.
Microbiological investigation.
Blood from the RBCC was plated
on MacConkey, sheep blood (aerobe), and Schaedler (anaerobe) agar
plates. After 1 day of incubation (at 37°C), small colonies that were
identified as Yersinia enterocolitica by using a numeric
profile based on 20 biochemical reactions (API 20E) were found. The
fresh frozen plasma from the same donation showed no growth, as it had
been stored in a frozen state. Twenty-five days after the blood
donation, a stool specimen from the donor was examined by a
cold-enrichment technique (10 days in phosphate-buffered saline at
4°C) (28), which also revealed Y. enterocolitica. Direct inoculation of the stool sample on
cefsulodin-irgasan-novobiocin agar (28°C) (22) had been
negative. The isolates from the blood bag and from the donor's stool
were characterized as serotype O:9 (by agglutination with anti-Y.
enterocolitica sera) and as biotype II (by using commercial tests
with 20 and 49 biochemical reactions [API 20E and API 50CHE] and by
additional testing of the indole reaction with a prolonged incubation
of 4 days at 29°C). The antimicrobial susceptibility patterns of the
isolates were in concordance with data reported in the literature
(18). By genomic macrorestriction analysis using
NotI digestion of chromosomal DNA and pulsed-field gel
electrophoresis, identical restriction fragment patterns were obtained
from both isolates (26).
The donor's plasma (from the time of blood donation) contained
agglutinating antibodies against Y. enterocolitica O-antigen O:9 at a titer of 1:160 as measured by the Widal method (normal level,
1:80). In the immunoblot analysis we found antibodies of the
immunoglobulin M (IgM) class against YopD and antibodies of the IgA
class and of the IgG class against YopM (weak), YopH, YopD, and YopE
(13, 15, 17) (Fig. 1).

View larger version (44K):
[in this window]
[in a new window]
|
FIG. 1.
Immunoblot analysis of donor plasma (dilution, 1:200)
for antibodies of the IgG (lane G), IgA (lane A), and IgM (lane M)
classes against the Yops YopE, -D, -H, and -M.
|
|
The RBCC (buffy coat reduced, suspended in the additive solution SAG-M)
causing the adverse transfusion reaction had been
stored for 14 days in
the refrigerator and had stayed at room
temperature for some hours
before transfusion. The donor was apparently
healthy at the time of
donation. After the event he was questioned
again. He then remembered a
very mild and short-lasting diarrhea
without any other symptoms about
14 days before blood donation.
This had not reduced his fitness for
work so that he had forgotten
it in the
meantime.
The first case of transfusion-associated sepsis caused by
Y. enterocolitica was reported from The Netherlands in 1975 (
4).
Since that time more than 35 further cases from all
over the world
have been reported (
16). Autologous as well
as homologous blood
products were found to be contaminated with
Y. enterocolitica (
12); C. Richards, J. Kolins, and C. D. Trindade, Letter, JAMA
268:1541-1542, 1992. Most
reports concerned red blood cell
products (whole blood or RBCC)
(
16). Between April 1987 and
November 1996, 20 cases of
transfusion-associated
Y. enterocolitica sepsis (12 fatal)
were reported in the United States (
6,
7).
The true
incidence of this complication of blood transfusion is
not known,
because the report of nonfatal cases was not obligatory.
Although
transfusion-associated
Y. enterocolitica sepsis seems
to be
a rare event, it has received attention for its high fatality
rate
among the reported
patients.
From the results of our microbiological investigation we conclude that
Yersinia contamination of the blood donation was the
result
of a transient bacteremia of the donor, who suffered from
mild enteric
yersiniosis 2 weeks before blood donation. There
are only a few reports
on coisolation of
Y. enterocolitica from
donor blood and
feces that suggest this way of infection, but
our study adds a further
case in which identical strains were
isolated from the blood bag and
the stool sample. Obviously,
Y. enterocolitica is endowed
with properties enabling the pathogen
to cause symptomless transient
low-level bacteremia during reconvalescence
(
25). Recently,
the persistence of
Yersinia antigens in peripheral
white
blood cells from patients with
Y. enterocolitica infection
for up to 4 years has been demonstrated (
10).
Several approaches, such as reducing the storage time (
1,
8)
or the storage temperature of RBCCs (
3), asking donors
about
gastrointestinal illness in the last weeks before blood
donation
(
11), and inspecting the blood in the bags for color
change
a short time before the release of the units (
19), have
been
suggested for preventing transfusion-associated
Y. enterocolitica sepsis but have not yet been generally accepted.
Removal of
Y. enterocolitica from donated blood can be
achieved by leukocyte
filtration (
5,
9,
20,
29). However,
large numbers of
bacteria can exceed the capacity of this method to
prevent bacterial
growth during the storage of RBCCs (
5,
29). Testing for antibodies
against
Y. enterocolitica
O antigens in donor serum by the bacterial
agglutination method
(
23) or by an enzyme-linked immunosorbent
assay A. J. Morris and D. G. Woodfield, Letter, Transfusion
38:1122,
1998 has not been recommended, either because of an unacceptably
high rate of positive results for healthy donors (
23) or
because
of an apparent lack of antibody response in some patients
Morris
and Woodfield,
Letter.
Another possibility of serological testing is the detection of
antibodies against
Yersinia outer proteins (Yops)
(
13). Yops
are clearly associated with virulence properties
of pathogenic
strains (
24). They are borne by the virulence
plasmid pYV, which
is present in all human pathogenic
Yersinia species and serotypes
(
15). In contrast
to testing for antibodies to O antigens (
2),
screening for
antibodies to Yops is not restricted to single serotypes
(
21). Antibodies of the IgM class

especially those directed
against YopD

may indicate an acute infection (
27). A
preliminary
study with a small number of healthy blood donors had shown
a
specificity of 97% for immunoblot analysis for IgM antibodies
against Yops (
14). Further studies are required to evaluate
the suitability of the detection of IgM antibodies against Yops
for
reducing the risk of transfusion-associated
Y. enterocolitica sepsis.
 |
FOOTNOTES |
*
Corresponding author. Mailing address: Institut
für Medizinische Mikrobiologie, Immunologie und
Krankenhaushygiene, Städtisches Krankenhaus
München-Schwabing, Kölner Platz 1, D-80804 Munich, Germany.
Phone: 0049-89-3068-3360. Fax: 0049-89-3068-3835. E-mail: Mikrobiologie{at}kms.mhn.de.
 |
REFERENCES |
| 1.
|
Arduino, M. J.,
L. A. Bland,
M. A. Tipple,
S. M. Aguero,
M. S. Favero, and W. R. Jarvis.
1989.
Growth and endotoxin production of Yersinia enterocolitica and Enterobacter agglomerans in packed erythrocytes.
J. Clin. Microbiol.
27:1483-1485[Abstract/Free Full Text].
|
| 2.
|
Bottone, E. J., and D. J. Sheehan.
1983.
Yersinia enterocolitica: guidelines for serologic diagnosis of human infections.
Rev. Infect. Dis.
5:898-906[Medline].
|
| 3.
|
Bradley, R. M.,
R. M. Gander,
S. K. Patel, and H. S. Kaplan.
1997.
Inhibitory effect of 0°C storage on the proliferation of Yersinia enterocolitica in donated blood.
Transfusion
37:691-695[CrossRef][Medline].
|
| 4.
|
Bruining, M., and C. C. M. De Wilde-Beekhuizen.
1975.
A case of contamination of donor blood by Yersinia enterocolitica type 9.
Medikon
4:30-31.
|
| 5.
|
Buchholz, D. H.,
J. P. AuBuchon,
E. L. Snyder,
R. Kandler,
S. Edberg,
V. Piscitelli,
C. Pickard, and P. Napychank.
1992.
Removal of Yersinia enterocolitica from AS-1 red cells.
Transfusion
32:667-672[CrossRef][Medline].
|
| 6.
|
Centers for Disease Control and Prevention.
1991.
Update: Yersinia enterocolitica bacteremia and endotoxin shock associated with red blood cell transfusions United States, 1991.
Morb. Mortal. Wkly. Rep.
40:176-178[Medline].
|
| 7.
|
Centers for Disease Control and Prevention.
1997.
Red blood cell transfusions contaminated with Yersinia enterocolitica United States, 1991-1996, and initiation of a national study to detect bacteria-associated transfusion reactions.
JAMA
278:196-197[Abstract/Free Full Text].
|
| 8.
|
Franzin, L., and P. Gioannini.
1992.
Growth of Yersinia species in artificially contaminated blood bags.
Transfusion
32:673-676[CrossRef][Medline].
|
| 9.
|
Gong, J.,
C. F. Högman,
A. Hambraeus,
C. S. Johansson, and L. Eriksson.
1993.
Transfusion-transmitted Yersinia enterocolitica infection.
Vox Sang.
65:42-46[Medline].
|
| 10.
|
Granfors, K.,
R. Merilahti-Palo,
R. Luukkainen,
T. Möttönen,
R. Lahesmaa,
P. Probst,
E. Märker-Hermann, and P. Toivanen.
1998.
Persistence of Yersinia antigens in peripheral blood cells from patients with Yersinia enterocolitica O:3 infection with or without reactive arthritis.
Arthritis Rheum.
41:855-862[CrossRef][Medline].
|
| 11.
|
Grossman, B. J.,
P. Kollins,
P. M. Lau,
J. L. Perreten,
R. J. Bowman,
S. Malcolm, and W. M. Palko.
1991.
Screening blood donors for gastrointestinal illness: a strategy to eliminate carriers of Yersinia enterocolitica.
Transfusion
31:500-501[CrossRef][Medline].
|
| 12.
|
Haditsch, M.,
L. Binder,
C. Gabriel,
P. Müller-Uri,
R. Watschinger, and H. Mittermayer.
1994.
Yersinia enterocolitica septicemia in autologous blood transfusion.
Transfusion
34:907-909[CrossRef][Medline].
|
| 13.
|
Heesemann, J.,
C. Eggers,
J. Schröder, and R. Laufs.
1986.
Serological diagnosis of yersiniosis by the immunoblot technique using plasmid-encoded antigens of Yersinia enterocolitica, p. 79-88.
In
C. Simon, and P. Wilkinson (ed.), Diagnosis of infectious diseases new aspects. Schattauer, Stuttgart, Germany.
|
| 14.
|
Heesemann, J.,
C. Eggers, and J. Schröder.
1987.
Serological diagnosis of yersiniosis by immunoblot technique using virulence-associated antigen of enteropathogenic Yersiniae.
Contrib. Microbiol. Immunol.
9:285-289[Medline].
|
| 15.
|
Heesemann, J.,
U. Gross,
N. Schmidt, and R. Laufs.
1986.
Immunochemical analysis of plasmid-encoded proteins released by enteropathogenic Yersinia species grown in calcium-deficient media.
Infect. Immun.
54:561-567[Abstract/Free Full Text].
|
| 16.
|
Högman, C. F., and L. Engstrand.
1996.
Factors affecting growth of Yersinia enterocolitica in cellular blood products.
Transfus. Med. Rev.
10:259-275[CrossRef][Medline].
|
| 17.
|
Hoogkamp-Korstanje, J. A. A.,
J. de Koning, and J. Heesemann.
1988.
Persistence of Yersinia enterocolitica in man.
Infection
16:81-85[CrossRef][Medline].
|
| 18.
|
Kanazawa, Y.,
K. Ikemura, and T. Kuramata.
1987.
Drug susceptibility of Yersinia enterocolitica and Yersinia pseudotuberculosis.
Contrib. Microbiol. Immunol.
9:127-135[Medline].
|
| 19.
|
Kim, D. M.,
M. E. Brecher,
L. A. Bland,
T. J. Estes,
R. A. Carmen, and E. J. Nelson.
1992.
Visual identification of bacterially contaminated red cells.
Transfusion
32:221-225[CrossRef][Medline].
|
| 20.
|
Kim, D. M.,
M. E. Brecher,
L. A. Bland,
T. J. Estes,
S. K. McAllister,
S. M. Aguero,
R. A. Carmen, and E. J. Nelson.
1992.
Prestorage removal of Yersinia enterocolitica from red cells with white cell-reduction filters.
Transfusion
32:658-662[CrossRef][Medline].
|
| 21.
|
Mäki-Ikola, O.,
J. Heesemann,
R. Lahesmaa,
A. Toivanen, and K. Granfors.
1991.
Combined use of released proteins and lipopolysaccharide in enzyme-linked immunosorbent assay for serologic screening of Yersinia infections.
J. Infect. Dis.
163:409-412[Medline].
|
| 22.
|
Nash, P., and M. M. Krenz.
1991.
Culture media, p. 1237.
In
A. Balows, W. J. Hausler, K. L. Herrmann, H. D. Isenberg, and H. J. Shadomy (ed.), Manual of clinical microbiology, 5th ed. American Society for Microbiology, Washington, D.C.
|
| 23.
|
Prentice, M.
1992.
Transfusing Yersinia enterocolitica.
Br. Med. J.
305:663-664.
|
| 24.
|
Ruckdeschel, K.,
A. Roggenkamp,
S. Schubert, and J. Heesemann.
1996.
Differential contribution of Yersinia enterocolitica virulence factors to evasion of microbicidal action of neutrophils.
Infect. Immun.
64:724-733[Abstract].
|
| 25.
|
Ruckdeschel, K.,
S. Harb,
A. Roggenkamp,
M. Hornef,
R. Zumbihl,
S. Köhler,
J. Heesemann, and B. Rouot.
1998.
Yersinia enterocolitica impairs activation of transcription factor NF- B: involvement in the induction of programmed cell death and in the suppression of the macrophage tumor necrosis factor production.
J. Exp. Med.
187:1069-1079[Abstract/Free Full Text].
|
| 26.
|
Saken, E.,
A. Roggenkamp,
S. Aleksic, and J. Heesemann.
1994.
Characterisation of pathogenic Yersinia enterocolitica serogroups by pulsed-field gel electrophoresis of genomic NotI restriction fragments.
J. Med. Microbiol.
41:329-338[Abstract/Free Full Text].
|
| 27.
|
Stahlberg, T. H.,
J. Heesemann,
K. Granforrs, and A. Toivanen.
1989.
Immunoblot analysis of IgM, IgG and IgA responses to plasmid encoded released proteins of Yersinia enterocolitica in patients with and without Yersinia triggered reactive arthritis.
Ann. Rheum. Dis.
48:577-581[Abstract/Free Full Text].
|
| 28.
|
Van Noyen, R.,
R. Selderslaghs,
G. Wauters, and J. Vandepitte.
1987.
Optimal recovery of Yersinia enterocolitica O:3 and O:9 from stools of patients with intestinal disorders.
Contrib. Microbiol. Immunol.
9:272-278[Medline].
|
| 29.
|
Wenz, B.,
E. R. Burns, and L. F. Freundlich.
1992.
Prevention of growth of Yersinia enterocolitica in blood by polyester fiber filtration.
Transfusion
32:663-666[CrossRef][Medline].
|
Journal of Clinical Microbiology, July 2000, p. 2788-2790, Vol. 38, No. 7
0095-1137/00/$04.00+0
Copyright © 2000, American Society for Microbiology. All rights reserved.
This article has been cited by other articles:
-
Ribault, S., Faucon, A., Grave, L., Nannini, P., Faure, I. B.
(2005). Detection of Bacteria in Red Blood Cell Concentrates by the Scansystem Method. J. Clin. Microbiol.
43: 2251-2255
[Abstract]
[Full Text]